MedRisk’s $1.15 Billion Acquisition Financing

Shearman advised UBS, as first-lien and second-lien Administrative Agent on the deal.

UBS granted a $1.15 billion acquisition financing, consisting of a $750 million first-lien term loan facility, a $300 million second-lien term loan facility, and a $100 million revolving credit facility to finance a portion of the purchase price for the acquisition of a majority interest in Medrisk by Bella Holding Company, LLC (CVC Capital Partners).

MedRisk, LLC provides claims services and specialty managed care solutions. It provides claims workflow management tools, delayed recovery solutions, utilization review, and functional capacity evaluations. The company also offers services in the areas of physical therapy, occupational therapy, chiropractic care, functional capacity evaluations, hand therapy, aquatic therapy, acupuncture, and physical rehabilitation.

The Shearman & Sterling team advising UBS was led by partner Heather Waters Borthwick (Picture), partner Tomasz Kulawik, with associate Frank Oliver, and was supported by Nicholas Kho.

Involved fees earner: Tomasz Kulawik – Shearman & Sterling; Frank Oliver – Shearman & Sterling; Heather Waters Borthwick – White & Case;

Law Firms: Shearman & Sterling; White & Case;

Clients: UBS;

Author: Martina Bellini